🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04184583
Starting soon Observational

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

NCT04184583 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Anzhen Hospital
Phase
Observational
Started
2019-12
Last updated
2019-12-03

Condition(s) studied

Drug TherapyAcute Coronary Syndrome

Study summary

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Informed consent has been signed. * Patients diagnosed in our hospital with acute coronary syndrome. * Age ≥18. * Life expectancy ≥12 months. Exclusion Criteria: * Severe lack of important information such as history of previous medication, history of previous disease, history of surgery. * Pregnant and lactating women. * Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Anzhen Hospital Beijing Beijing Municipality

More Beijing Anzhen Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04184583 on ClinicalTrials.gov ↗ ← All trials in China